He Takes Yunnan Panax Pseudoginseng to the World

Tang Xiuwen, Chairman & President of the Daphne pharmaceutical Co., Ltd., Yunnan

      Tang Xiuwen is busy. For the sake of development of Daphne and what's more important, Yunnan's panax pseudoginseng industry，he is concentrating nearly 95% of his energy on the work. This year marks the 10^th anniversary of Daphne and formation of Daphne group. The outstanding performance provides another reason for the Daphne staff to have a good celebration fest. But Tang Xiuwen didn't do that. In his mind, a dream is still yet to be realized: to push the Yunnan panax pseudoginseng onto the global market. Maybe on the day when this dream comes true, beaming Tang Xiuwen will have the mood to celebrate it heartily.

Through effort over a decade, Daphne has grown into a leading enterprise with annual output value of RMB 200 million yuan and driving development of the local panax pseudoginseng planting industry. Now, the Company owns 7 subsidiaries, and more than 20 offices. In 2003, Daphne reported profits and taxes of more than RMB 19 million yuan. The enterprise has been listed as a certified high-tech enterprise in Yunnan, a provincial top 100 private enterprise and one of the ten pharmaceutical enterprises to receive preemptive support from the provincial government.

This July, Yunnan Daphne and the Shanghai Pharmaceutical Group majority-owned by the Huayuan Co. signed an agreement on strategic cooperation framework for Wenshan panax pseudoginseng business. Pursuant to this agreement, the two sides will co-establish a company called the Yunnan Panax Pseudoginseng Industry Group and forge it into a China leading panax pseudoginseng group in line with international practice integrating panax pseudoginseng seedling, GAP-compliant panax pseudoginseng planting base construction, panax pseudoginseng resource processing & extraction, panax pseudoginseng product R&D, and upgrading of the panax pseudoginseng industry. The Shanghai Pharmaceutical Group, due to be listed on overseas market in 2005, will highlight the Yunnan panax pseudoginseng project in its prospectus and road shows, which will help clear way for the panax pseudoginseng products to gain an access to the global market.

In August, the Daphne Group and Japanese Sanwa Int'l Co., Ltd. signed a contract in Wenshan, whereby the two sides will co-sponsor a joint venture named Daphne Co., Ltd. in Japan. On October 18, construction of the Wenshan Panax Pseudoginseng Trading Center kicked off.

Tang Xiuwen is improving the awareness of Yunnan panax pseudoginseng across the country, and embarking on introduction of the Yunnan panax pseudoginseng to the world.

Sourced: Yunnan Information Daily, Candidates of Yunnan Financial & Economic Persons